Oxomics’ New Blood-Based Test the First to Identify if a Patient has Cancer and if it has SpreadGemma Cann2023-09-04T12:46:40+01:00January 11th, 2022|News|
New Antibiotic Resistance Test Developed by AGPlus DiagnosticsGemma Cann2022-06-30T11:58:06+01:00August 25th, 2021|Colworth Park, News|
Concepta Inks Global License Agreement with Abingdon HealthGemma Cann2022-06-30T11:58:30+01:00August 25th, 2021|Colworth Park, News|
Stream Bio Works with MIP Diagnostics on Rapid Diagnostic and Mass Screening Test for COVID-19Gemma Cann2022-06-30T11:59:32+01:00August 25th, 2021|Colworth Park, News|
Veravas and MIP Diagnostics Announce International Agreement for Improved DiagnosticsGemma Cann2022-06-30T11:59:48+01:00August 25th, 2021|Colworth Park, News|
AgPlus Developing Two Assays to Support the COVID-19 Diagnostic EffortGemma Cann2022-06-30T12:00:18+01:00August 25th, 2021|Colworth Park, News|
MIP Diagnostics Signs Significant Commercial AgreementGemma Cann2022-06-30T12:00:27+01:00August 25th, 2021|Colworth Park, News|
Almac Discovery Expands Disease Focus into Respiratory DiseaseGemma Cann2022-06-30T12:01:14+01:00July 20th, 2021|Edinburgh Technopole|
